Are basophil activation and sulphidoleukotriene determination useful tests for monitoring patients with peach allergy receiving sublingual immunotherapy with a Pru p 3-enriched peach extract?

Journal of Investigational Allergology and Clinical Immunology

Volumn 24, Issue 2, 2014, Pages 106-113

  Garrido Fernández, Sara ^a   Garcia B E ^a   Sanz, M L ^b   Echechipia S ^a   Lizaso, M T ^a   Tabar, A I ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Basophil; CAST; Food immunotherapy; Lipid transfer protein; LTP; Peach immunotherapy; Sublingual immunotherapy

Indexed keywords

FOOD ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; LEUKOTRIENE DERIVATIVE; LIPID TRANSFER PROTEIN; PEACH EXTRACT; PLANT EXTRACT; PRU P 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASOPHIL; BASOPHIL ACTIVATION TEST; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; EXTRACTION AND EXTRACTS; FEMALE; FOOD ALLERGY; HUMAN; IMMUNOSTIMULATION; IMMUNOTHERAPY; MALE; PATIENT MONITORING; PEACH; QUANTITATIVE ASSAY; RANDOMIZED CONTROLLED TRIAL; SULPHIDOLEUKOTRIENE DETERMINATION; TREATMENT OUTCOME;

ADULT; ANTIGENS, PLANT; BASOPHILS; DOUBLE-BLIND METHOD; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEUKOTRIENES; MALE; PLANT EXTRACTS; PLANT PROTEINS; PRUNUS; SUBLINGUAL IMMUNOTHERAPY;

EID: 84901919089     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mempel M, Rakoski J, Ring J, Ollert M. Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol. 2003; 111:1406-9.
2. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, Schroeder JT, Hamilton RG, Boden S, Steele P, Driggers S, Burks AW, Wood RA. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2012; 129:448-55.
3. Enrique E, Pineda F, Malek T, Bartra J, Basagana M, Tella R, Castelló JV, Alonso R, de Mateo JA, Cerdá-Trias T, San Miguel-Moncín Mdel M, Monzón S, García M, Palacios R, Cisteró-Bahíma A. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. 2005; 116:1073-9.
4. Kim EH, Bird JA, Kulis M, Laubach S, Pons L, Shreffler W, Shreffler W, Steele P, Kamilaris J, Vickery B, Burks AW. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2011; 127:640-6.
5. Jutel M, Muller UR, Fricker M, Rihs S, Pichler WJ, Dahinden C. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy. 1996; 26:1112-8.
6. Plewako H, Wosinska K, Arvidsson M, Bjorkander J, Skov PS, Hakansson L, Rak S. Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy. Int Arch Allergy Immunol. 2006; 141:346-53.
7. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2007; 119:780-91.
8. Gastaminza G, Algorta J, Uriel O, Audicana MT, Fernandez E, Sanz ML, Muñoz D. Randomized, double-blind, placebocontrolled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients. Trials. 12:191.
9. Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Devillier P, Montagut A, Mélac M, Galvain S, Jean-Alphonse S, Van Overtvelt L, Moingeon P, Le Gall M. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. J Allergy Clin Immunol. 2009; 124:471-7.
10. Van Overtvelt L, Baron-Bodo V, Horiot S, Moussu H, Ricarte C, Horak F, Zieglmayer P, Zieglmayer R, Montagut A, Galvain S, de Beaumont O, Le Gall M, Moingeon P. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy. Allergy. 66:1530-7.
11. Fernandez-Rivas M, Garrido Fernandez S, Nadal JA, Alonso Diaz de Durana MD, Garcia BE, Gonzalez-Mancebo E, Martin S, Barber D, Rico P, Tabar AI. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy. 2009; 64:876-83.
12. Malling HJ, Weeke B. Position paper: Immunotherapy. EAACI Immunotherapy Subcommittee. Allergy. 1993; 48(Suppl 14):9-35.
13. Duffort OA, Polo F, Lombardero M, Diaz-Perales A, Sanchez-Monge R, Garcia-Casado G, Salcedo G, Barber D. Immunoassay to quantify the major peach allergen Pru p 3 in foodstuffs. Differential allergen release and stability under physiological conditions. J Agric Food Chem. 2002; 50:7738-41.
14. Diaz-Perales A, Garcia-Casado G, Sanchez-Monge R, Garcia-Selles FJ, Barber D, Salcedo G. cDNA cloning and heterologous expression of the major allergens from peach and apple belonging to the lipid-transfer protein family. Clin Exp Allergy. 2002; 32:87-92.
15. Petersen AB, Gudmann P, Milvang-Gronager P, Morkeberg R, Bogestrand S, Linneberg A, Johansen N. Performance evaluation of a specific IgE assay developed for the ADVIA centaur immunoassay system. Clin Biochem. 2004; 37:882-92.
16. Gamboa PM, Caceres O, Antepara I, Sanchez-Monge R, Ahrazem O, Salcedo G, Barber D, Lombardero M, Sanz ML. Two different profiles of peach allergy in the north of Spain. Allergy. 2007; 62:408-14.
17. Diaz-Perales A, Sanz ML, Garcia-Casado G, Sanchez-Monge R, Garcia-Selles FJ, Lombardero M, Polo F, Gamboa PM, Barber D, Salcedo G. Recombinant Pru p 3 and natural Pru p 3, a major peach allergen, show equivalent immunologic reactivity: a new tool for the diagnosis of fruit allergy. J Allergy Clin Immunol. 2003; 111:628-33.
18. Sanz ML, Garcia-Aviles MC, Tabar AI, Anda M, Garcia BE, Barber D, Salcedo G, Rihs HP, Raulf-Heimsoth M. Basophil Activation Test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children. Pediatr Allergy Immunol. 2006; 17:148-56.
19. Gamboa PM, Sanz ML, Lombardero M, Barber D, Sanchez-Monje R, Goikoetxea MJ, Antepara I, Ferrer M, Salcedo G. Component-resolved in vitro diagnosis in peach-allergic patients. J Investig Allergol Clin Immunol. 2009; 19:13-20.
20. De Weck AL, Stadler BM, Urwyler A, Wehner HU, Buhlman RP. Cellullar allergen stimulation test (CAST). A new dimension in allergy diagnostics. Allergy Clin Immunol News. 1993; 5:9-14.
21. Chinchilli VM, Fisher L, Craig TJ. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge. J Allergy Clin Immunol. 2005; 115:592-7.
22. James LK, Durham SR. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy. 2008; 38:1074-88.
23. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR, Nair MG, Du Y, Zaph C, van Rooijen N, Comeau MR, Pearce EJ, Laufer TM, Artis D. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokinedependent immunity. Nat Immunol. 2009; 10:697-705.
24. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergeninduced T helper type 2 response. Nat Immunol. 2009; 10:713-20.
25. Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y, Nakanishi K. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol. 2009; 10:706-12.
26. Gaier S, Marsh J, Oberhuber C, Rigby NM, Lovegrove A, Alessandri S, Briza P, Radauer C, Zuidmeer L, van Ree R, Hemmer W, Sancho AI, Mills C, Hoffmann-Sommergruber K, Shewry PR. Purification and structural stability of the peach allergens Pru p 1 and Pru p 3. Mol Nutr Food Res. 2008; 52 Suppl 2:S220-9.
27. Vieths S, Scheurer S, Ballmer-Weber B. Current understanding of cross-reactivity of food allergens and pollen. Ann N Y Acad Sci. 2002; 964:47-68.
28. Kinaciyan T, Jahn-Schmid B, Radakovics A, Zwolfer B, Schreiber C, Francis JN, Ebner C, Bohle B. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol. 2007; 119:937-43.
29. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol. 2007; 120:707-13.